Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Maddahi, Aida ^a   Povlsen, Gro ^b   Edvinsson, Lars ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

IL 1 ; IL 6; MMP 9; Phosphorylated ERK1 2; Subarachnoid hemorrhage; TNF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; BRAIN ARTERY; BRAIN BLOOD VESSEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MALE; NERVOUS SYSTEM FUNCTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SENSORIMOTOR FUNCTION; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; UPREGULATION; WESTERN BLOTTING;

EID: 84871376780     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-274     Document Type: Article

References (65)

1. Rose MJ. Aneurysmal subarachnoid hemorrhage: an update on the medical complications and treatments strategies seen in these patients. Curr Opin Anaesthesiol 2011, 24:500-507. 10.1097/ACO.0b013e32834ad45b, 21869679.
2. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003, 53:123-133. 10.1227/01.NEU.0000068863.37133.9E, 12823881.
3. Muroi C, Mink S, Seule M, Bellut D, Fandino J, Keller E. Monitoring of the inflammatory response after aneurysmal subarachnoid haemorrhage in the clinical setting: review of literature and report of preliminary clinical experience. Acta Neurochir Suppl 2011, 110:191-196. 10.1007/978-3-7091-0353-1_33, 21116938.
4. Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006, 26:1341-1353. 10.1038/sj.jcbfm.9600283, 16482081.
5. Peterson JW, Kwun BD, Hackett JD, Zervas NT. The role of inflammation in experimental cerebral vasospasm. J Neurosurg 1990, 72:767-774. 10.3171/jns.1990.72.5.0767, 2182792.
6. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schütt S, Fritzinger M, Horn P, Vajkoczy P, Kreisel S, Brunner J, Schmiedek P, Hennerici M. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 2001, 70:534-537. 10.1136/jnnp.70.4.534, 1737308, 11254783.
7. Gaetani P, Tartara F, Pignatti P, Tancioni F, Rodriguez y Baena R, De Benedetti F. Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 1998, 20:337-342.
8. Kasuya H, Shimizu T. Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage. J Neurosurg 1989, 71:741-746. 10.3171/jns.1989.71.5.0741, 2809729.
9. Kwon KY, Jeon BC. Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci 2001, 16:774-780. 3054809, 11748361.
10. Mack WJ, Mocco J, Hoh DJ, Huang J, Choudhri TF, Kreiter KT, Lozier A, Opperman M, Poisik A, Yorgason J, Solomon RA, Mayer SA, Connolly ES. Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002, 96:71-75. 10.3171/jns.2002.96.1.0071, 11794607.
11. Polin RS, Bavbek M, Shaffrey ME, Billups K, Bogaev CA, Kassell NF, Lee KS. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 1998, 89:559-567. 10.3171/jns.1998.89.4.0559, 9761049.
12. Pellettieri L, Nilsson B, Carlsson CA, Nilsson U. Serum immunocomplexes in patients with subarachnoid hemorrhage. Neurosurgery 1986, 19:767-771. 10.1227/00006123-198611000-00008, 3785623.
13. McFaul SJ, Bowman PD, Villa VM. Hemoglobin stimulates the release of proinflammatory cytokines from leukocytes in whole blood. J Lab Clin Med 2000, 135:263-269. 10.1067/mlc.2000.105180, 10711865.
14. Prunell GF, Svendgaard NA, Alkass K, Mathiesen T. Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery 2005, 56:1082-1092.
15. Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol 2002, 88:227-249. 10.1254/jjp.88.227, 11949877.
16. Mathiesen T, Andersson B, Loftenius A, von Holst H. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 1993, 78:562-567. 10.3171/jns.1993.78.4.0562, 8450329.
17. Mathiesen T, Edner G, Ulfarsson E, Andersson B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg 1997, 87:215-220. 10.3171/jns.1997.87.2.0215, 9254084.
18. Kikuchi T, Okuda Y, Kaito N, Abe T. Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage. Neurol Res 1995, 17:106-108.
19. Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, Zhang JH. Immunological response in early brain injury after SAH. Acta Neurochir Suppl 2011, 110:57-61. 10.1007/978-3-7091-0353-1_10, 21116915.
20. Chou SH, Feske SK, Simmons SL, Konigsberg RG, Orzell SC, Marckmann A, Bourget G, Bauer DJ, De Jager PL, Du R, Arai K, Lo EH, Ning MM. Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Transl Stroke Res 2011, 2:600-607. 10.1007/s12975-011-0117-x, 3236293, 22207885.
21. McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 2002, 51:1128-1134. 10.1097/00006123-200211000-00005, 12383357.
22. Wang Z, Fang Q, Dang BQ, Shen XM, Shu Z, Zuo G, He WC, Chen G. Potential contribution of matrix metalloproteinase-9 (mmp-9) to cerebral vasospasm after experimental subarachnoid hemorrhage in rats. Ann Clin Lab Sci 2012, 42:14-20.
23. Rosell A, Ortega-Aznar A, Alvarez-Sabin J, Fernandez-Cadenas I, Ribo M, Molina CA, Lo EH, Montaner J. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 2006, 37:1399-1406. 10.1161/01.STR.0000223001.06264.af, 16690896.
24. Horstmann S, Su Y, Koziol J, Meyding-Lamade U, Nagel S, Wagner S. MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage. J Neurol Sci 2006, 251:82-86. 10.1016/j.jns.2006.09.005, 17087971.
25. Sarrafzadeh A, Copin JC, Bengualid DJ, Turck N, Vajkoczy P, Bijlenga P, Schaller K, Gasche Y. Matrix metalloproteinase-9 concentration in the cerebral extracellular fluid of patients during the acute phase of aneurysmal subarachnoid hemorrhage. Neurol Res 2012, 34:455-461. 10.1179/1743132812Y.0000000018, 22449315.
26. Feiler S, Plesnila N, Thal SC, Zausinger S, Scholler K. Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage. Cerebrovasc Dis 2011, 32:289-295. 10.1159/000328248, 21912109.
27. Guo ZD, Sun XC, Zhang JH. Mechanisms of early brain injury after SAH: matrix metalloproteinase 9. Acta Neurochir Suppl 2011, 110:63-65. 10.1007/978-3-7091-0353-1_11, 21116916.
28. Vikman P, Beg S, Khurana T, Hansen-Schwartz J, Edvinsson L. Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat. J Neurosurg 2006, 105:438-444. 10.3171/jns.2006.105.3.438, 16961140.
29. Maddahi A, Ansar S, Chen Q, Edvinsson L. Blockade of the MEK/ERK pathway with a raf inhibitor prevents activation of pro-inflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model. J Cereb Blood Flow Metab 2011, 31:144-154. 10.1038/jcbfm.2010.62, 3049479, 20424636.
30. Prunell GF, Mathiesen T, Diemer NH, Svendgaard NA. Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery 2003, 52:165-175.
31. Prunell GF, Mathiesen T, Svendgaard NA. A new experimental model in rats for study of the pathophysiology of subarachnoid hemorrhage. Neuroreport 2002, 13:2553-2556. 10.1097/00001756-200212200-00034, 12499866.
32. Ohlsson AL, Johansson BB. Environment influences functional outcome of cerebral infarction in rats. Stroke 1995, 26:644-649. 10.1161/01.STR.26.4.644, 7709412.
33. Larsen CC, Povlsen GK, Rasmussen MN, Edvinsson L. Improvement in neurological outcome and abolition of cerebrovascular endothelin B and 5-hydroxytryptamine 1B receptor upregulation through mitogen-activated protein kinase kinase 1/2 inhibition after subarachnoid hemorrhage in rats. J Neurosurg 2011, 114:1143-1153. 10.3171/2010.6.JNS1018, 20597604.
34. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994, 25:1481-1488. 10.1161/01.STR.25.7.1481, 8023366.
35. Matsuo Y, Onodera H, Shiga Y, Nakamura M, Ninomiya M, Kihara T, Kogure K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 1994, 25:1469-1475. 10.1161/01.STR.25.7.1469, 8023364.
36. Provencio JJ, Fu X, Siu A, Rasmussen PA, Hazen SL, Ransohoff RM. CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage. Neurocrit Care 2010, 12:244-251. 10.1007/s12028-009-9308-7, 2844469, 19967568.
37. Bednar MM, Gross CE, Howard DB, Lynn M. Neutrophil activation in acute human central nervous system injury. Neurol Res 1997, 19:588-592.
38. Ansar S, Edvinsson L. Subtype activation and interaction of protein kinase C and mitogen-activated protein kinase controlling receptor expression in cerebral arteries and microvessels after subarachnoid hemorrhage. Stroke 2008, 39:185-190. 10.1161/STROKEAHA.107.487827, 18032736.
39. Dankbaar JW, Rijsdijk M, van der Schaaf IC, Velthuis BK, Wermer MJ, Rinkel GJ. Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology 2009, 51:813-819. 10.1007/s00234-009-0575-y, 2773037, 19623472.
40. Chen G, Zhang S, Shi J, Ai J, Hang C. Effects of recombinant human erythropoietin (rhEPO) on JAK2/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage. Cytokine 2009, 45:162-168. 10.1016/j.cyto.2008.11.015, 19144539.
41. Friedrich V, Flores R, Sehba FA. Cell death starts early after subarachnoid hemorrhage. Neurosci Lett 2012, 512:6-11. 10.1016/j.neulet.2012.01.036, 22306092.
42. Wang Z, Meng CJ, Shen XM, Shu Z, Ma C, Zhu GQ, Liu HX, He WC, Sun XB, Huo L, Zhang J, Chen G. Potential contribution of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhage. J Mol Neurosci 2012, 48:273-280. 10.1007/s12031-012-9769-6, 22528459.
43. Ducruet AF, Gigante PR, Hickman ZL, Zacharia BE, Arias EJ, Grobelny BT, Gorski JW, Mayer SA, Connolly ES. Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 2010, 30:676-688. 10.1038/jcbfm.2009.278, 2949164, 20068580.
44. Edvinsson LI, Povlsen GK. Vascular plasticity in cerebrovascular disorders. J Cereb Blood Flow Metab 2011, 31:1554-1571. 10.1038/jcbfm.2011.70, 3137480, 21559027.
45. Zaremba J, Losy J. Cytokines in clinical and experimental ischemic stroke. Neurol Neurochir Pol 2004, 38:S57-62.
46. Uno H, Matsuyama T, Akita H, Nishimura H, Sugita M. Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab 1997, 17:491-499.
47. McMillian MK, Thai L, Hong JS, O'Callaghan JP, Pennypacker KR. Brain injury in a dish: a model for reactive gliosis. Trends Neurosci 1994, 17:138-142. 10.1016/0166-2236(94)90086-8, 7517589.
48. Wang CX, Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol 2002, 67:161-172. 10.1016/S0301-0082(02)00010-2, 12126659.
49. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997, 28:1233-1244. 10.1161/01.STR.28.6.1233, 9183357.
50. Vikman P, Ansar S, Edvinsson L. Transcriptional regulation of inflammatory and extracellular matrix-regulating genes in cerebral arteries following experimental subarachnoid hemorrhage in rats. Laboratory investigation. J Neurosurg 2007, 107:1015-1022. 10.3171/JNS-07/11/1015, 17977275.
51. Vecchione C, Frati A, Di Pardo A, Cifelli G, Carnevale D, Gentile MT, Carangi R, Landolfi A, Carullo P, Bettarini U, Antenucci G, Mascio G, Busceti CL, Notte A, Maffei A, Cantore GP, Lembo G. Tumor necrosis factor-alpha mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage. Hypertension 2009, 54:150-156. 10.1161/HYPERTENSIONAHA.108.128124, 19470883.
52. Haqqani AS, Nesic M, Preston E, Baumann E, Kelly J, Stanimirovic D. Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS. FASEB J 2005, 19:1809-1821. 10.1096/fj.05-3793com, 16260651.
53. Zemke D, Farooq MU, Mohammed Yahia A, Majid A. Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?. Vasc Med 2007, 12:243-249. 10.1177/1358863X07081316, 17848485.
54. Cheranov SY, Jaggar JH. TNF-alpha dilates cerebral arteries via NAD(P)H oxidase-dependent Ca2+ spark activation. Am J Physiol Cell Physiol 2006, 290:C964-971. 1638900, 16267103.
55. Handa Y, Kabuto M, Kobayashi H, Kawano H, Takeuchi H, Hayashi M. The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model. Neurosurgery 1991, 28:542-549. 10.1227/00006123-199104000-00010, 2034349.
56. Pannu H, Kim DH, Guo D, King TM, Van Ginhoven G, Chin T, Chang K, Qi Y, Shete S, Milewicz DM. The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms. J Neurosurg 2006, 105:418-423. 10.3171/jns.2006.105.3.418, 17328268.
57. Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 1999, 842:92-100. 10.1016/S0006-8993(99)01843-0, 10526099.
58. Jin D, Sheng J, Yang X, Gao B. Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm. Surg Neurol 2007, 68(Suppl 2):S11-16.
59. Vikman P, Ansar S, Henriksson M, Stenman E, Edvinsson L. Cerebral ischemia induces transcription of inflammatory and extracellular-matrix-related genes in rat cerebral arteries. Exp Brain Res 2007, 183:499-510. 10.1007/s00221-007-1062-5, 17828393.
60. Maddahi A, Chen Q, Edvinsson L. Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat. BMC Neurosci 2009, 10:56. 10.1186/1471-2202-10-56, 2700114, 19497125.
61. Rosenberg GA, Sullivan N, Esiri MM. White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke 2001, 32:1162-1168. 10.1161/01.STR.32.5.1162, 11340226.
62. Satoh M, Parent AD, Zhang JH. Inhibitory effect with antisense mitogen-activated protein kinase oligodeoxynucleotide against cerebral vasospasm in rats. Stroke 2002, 33:775-781. 10.1161/hs0302.103734, 11872903.
63. Chen D, Chen JJ, Yin Q, Guan JH, Liu YH. Role of ERK1/2 and vascular cell proliferation in cerebral vasospasm after experimental subarachnoid hemorrhage. Acta Neurochir (Wien) 2009, 151:1127-1134.
64. Pluta RM, Butman JA, Schatlo B, Johnson DL, Oldfield EH. Subarachnoid hemorrhage and the distribution of drugs delivered into the cerebrospinal fluid. Laboratory investigation. J Neurosurg 2009, 111:1001-1007. 10.3171/2009.2.JNS081256, 19374502.
65. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 2005, 103:9-17. 10.3171/jns.2005.103.1.0009, 16121967.